Concord Medical Services (NYSE:CCM) Share Price Crosses Above 200 Day Moving Average – Here’s Why

Concord Medical Services Holdings Limited (NYSE:CCM) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.13 and traded as high as $5.03. Concord Medical Services shares last traded at $4.8640, with a volume of 62,855 shares trading hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Concord Medical Services in a research report on Tuesday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has a consensus rating of “Sell”.

Concord Medical Services Trading Down 0.5%

The stock’s 50-day moving average is $4.22 and its 200 day moving average is $4.13. The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33.

Concord Medical Services (NYSE:CCM) last announced its quarterly earnings data on Wednesday, April 29th. The company reported ($1.08) EPS for the quarter.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.